Target intelligence / Profile preview

Transmembrane protein 230 pseudogene 2 (TMEM230P2)

Target
TMEM230P2
Molecular classification
Other
01

Overview

TMEM230P2 is a pseudogene related to the Transmembrane Protein 230 (TMEM230) gene. It is a genomic sequence similar to TMEM230 but does not encode a functional protein. Pseudogenes typically arise from gene duplication or retrotransposition events, and they usually lack biological activity. While TMEM230 is implicated in synaptic vesicle trafficking, angiogenesis, neurodegenerative diseases, and cancer, there is no evidence that TMEM230P2 encodes a protein or functions as a therapeutic target[5]. Notes: - TMEM230P2 should not be confused with the functional TMEM230 gene or its protein product; TMEM230P2 itself does not have a direct role in drug targeting or disease but serves as a genomic remnant or potential regulatory RNA[5]. - The presence of "pseudogene" in the name, its annotation in GeneCards, and the absence of protein-coding and functional data confirm that it is not considered a receptor, enzyme, transporter, or therapeutic target. There is nothing structurally, functionally, or pharmacologically actionable directly associated with TMEM230P2[5]. Summary: TMEM230P2 is not an actionable therapeutic target, and entries related to therapeutic action, biology, or pharmacology should be marked as null for this pseudogene[5].

Other names
TMEM230P2Transmembrane Protein 230 Pseudogene 2

Beyond the preview

Go deeper on Transmembrane protein 230 pseudogene 2 (TMEM230P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 230 pseudogene 2 (TMEM230P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call